| Literature DB >> 19025584 |
Eri Fukuda1, Katarzyna H Kaminska, Janusz M Bujnicki, Ichizo Kobayashi.
Abstract
BACKGROUND: Alteration in epigenetic methylation can affect gene expression and other processes. In Prokaryota, DNA methyltransferase genes frequently move between genomes and present a potential threat. A methyl-specific deoxyribonuclease, McrBC, of Escherichia coli cuts invading methylated DNAs. Here we examined whether McrBC competes with genome methylation systems through host killing by chromosome cleavage.Entities:
Mesh:
Substances:
Year: 2008 PMID: 19025584 PMCID: PMC2614495 DOI: 10.1186/gb-2008-9-11-r163
Source DB: PubMed Journal: Genome Biol ISSN: 1474-7596 Impact factor: 13.583
Figure 1Host killing by RM systems and by methyl-specific DNases (McrBC) in competition. (a) When a resident RM gene complex is replaced by a competitor genetic element, a decrease in the modification enzyme level results in exposure of newly replicated chromosomal restriction sites to lethal cleavage by the remaining restriction enzyme molecules. The intact genome copies will survive in uninfected neighboring clonal cells. (b) When a DNA methylation system enters a cell and begins to methylate chromosomal recognition sites, McrBC senses the change and triggers cell death by chromosomal cleavage. The intact genome copies will survive in uninfected neighboring clonal cells.
Plasmids
| Plasmids | Prototype | Relevant characteristics | Drug resistance | Source, reference |
| pBR322 | pBR322 | Ap, Tc | Laboratory collection [ | |
| pUC19 | pUC19 | Ap | Laboratory collection [ | |
| PACYC184 | pACYC184 | Cm, Tc | Laboratory collection [ | |
| pSC101 | pSC101 | Tc | National Institute of Genetics [ | |
| pBAD18 | pBR322 | PBAD | Ap | National Institute of Genetics [ |
| pIK8004 | pBR322 | NotI linker (GCGGCCGC) in DraI site | Ap | M. Kawai (our laboratory) |
| PYNEC302 | pUC19 | Ap | Y Nakayama [ | |
| PYNEC313 | pBR322 | Ap | Y Nakayama [ | |
| PYNEC404 | pUC19 | Ap | Y Nakayama [ | |
| pNY43 | pBR322 | Ap | Y Naito [ | |
| pNY44 | pBR322 | Ap | Y Naito [ | |
| pEF1 | pBR322 | PBAD, | Ap | This work |
| pEF23 | pBR322 | PBAD, | Ap | This work |
| pEF24 | pSC101 | PBAD, | Ap | This work |
| pEF30 | pBR322 | Ap | This work | |
| pEF33 | pBR322 | No PvuII site | Ap, Tc | This work |
| pEF43 | pBR322 | Ap | This work | |
| pKD13 | Ap, Km | |||
| pKD46 | pSC101(Ts) ori, | Ap | ||
| pCP20 | pSC101(Ts) ori, Pr-FLP | Ap | ||
| pBAD30 | pACYC184 | PBAD | Cm | National Institute of genetics [ |
| pSI4 | pUC19 | Ap | C. Karreman [ | |
| pNW106RM2-3 | pBR322 | Ap | New England Biolabs [ | |
| pEF46 | PBAD- | Cm | This work | |
| pUC4K | pBR322 | Ap, Km | Laboratory collection [ | |
| pEF60 | pBR322 | Km | This work | |
| pPvuCat16 | pPvu1 | pPvu1 ori, | Cm | Robert Blumenthal [ |
| pPvuCat17 | pPvu1 | pPvu1 ori | Cm | Robert Blumenthal [ |
| pEF65 | pPvu1 | pPvu1 ori, | Km | This work |
| pEF67 | pPvu1 | pPvu1 ori | Km | This work |
Ap, ampicillin-resistance; Cm, chloramphenicol-resistance; Km, kanamycin-resistance; Tc, tetracycline-resistance; Ts, temperature-sensitive.
Figure 2McrBC-mediated blocking of establishment of an epigenetic genome methylation system. (a) Quantitative transformation. Varying amounts of pUC19 (2 pg, 20 pg, 200 pg, 2 ng, 20 ng, and 200 ng) were used to transform E. coli DH5α by electroporation. Experiments were conducted in triplicate. (b) Transformation of plasmids carrying the PvuII methyltransferase gene. Plasmids (100 ng) carrying one of several modification methyltransferase genes were used to transform E. coli ER1562 (mcrB1) and ER1563 (mcrBC+). The relative transformation efficiency was calculated as the ratio of the transformation efficiency of the test plasmid to that of the empty vector. M.PvuII (ColE1) indicates pEF43, while M.PvuII (pPvu1) indicates pEF65 (Table 1). The empty vector for the latter is pEF67, while that for the former is pEF33. The vector for the remaining plasmids is pBR322. The measurements from two separate experiments conducted in duplicate are shown. All (20/20) of the rare transformants of mcrBC+ by pEF43 examined were found to have lost McrBC activity.
Figure 3McrBC-mediated inhibition of phage growth and chromosome cleavage. (a) Phage λ titer on ER1563 (mcrBC+) divided by its titer on ER1562 (mcrB1) is plotted for two independent experiments. (I) A λ strain with 15 PvuII sites (LIK891; see Materials and methods); (II) the same λ strain but modified by PvuII methyltransferase; (III) the same λ strain with insertion of PvuII methyltransferase gene (LEF1). (b) Chromosome degradation in ER1562 (mcrB1) and ER1563 (mcrBC+). 5 × 108 cells were infected with LEF1 at a multiplicity of infection of 5. At the indicated time intervals (in minutes) after infection of phage carrying the PvuII methyltransferase gene (LEF1), chromosomal DNA was prepared and subjected to pulsed-field agarose gel electrophoresis. M, λ DNA ladder.
Bacteria
| Genotype | Source and/or reference | |
| ER1562 | F- λ- | New England Biolabs [ |
| ER1563 | F- λ- | New England Biolabs [ |
| BIK18046 | ER1562 but Tcs | Tcs with fusaric acid |
| BIK18051 | ER1563 but Tcs | Tcs with fusaric acid |
| BIK18116 | ER1562 Δ( | KmR with pKD46-mediated transformation with PCR product from deletion allele primers and pKD13 template |
| BIK18118 | ER1563 Δ( | KmR with pKD46-mediated transformation with PCR product from deletion allele primers and pKD13 template |
| BIK18120 | ER1562 Δ | KmR with pKD46-mediated transformation with PCR product from deletion allele primers and pKD13 template |
| BIK18125 | ER1563 Δ | KmR with pKD46-mediated transformation with PCR product from deletion allele primers and pKD13 template |
| BIK18142 | ER1562 Δ | KmR with pKD46-mediated transformation with PCR product from deletion allele primers and pKD13 template |
| BW27269 | ||
| Δ(rhaBAD)568Δ | ||
| BW27535 | ||
| Δ(rhaBAD) 568 g(Δ | ||
| BIK18244 | BIK18046 Δ | P1 from BIK18116 to ER1562 |
| BIK18246 | BIK18051 Δ | P1 from BIK18116 to ER1563 |
| BIK18248 | BIK18046 Δ | BIK18244 Kms with pCP20 |
| BIK18249 | BIK18051 Δ | BIK18246 Kms with pCP20 |
| BIK18250 | BIK18046 Δ | P1 from BW27535 to BIK18248 |
| BIK18252 | BIK18051 Δ | P1 from BW27535 to BIK18249 |
| BIK18254 | BIK18046 Δ | BIK18250 Kms with pCP20 |
| BIK18255 | BIK18051 Δ | BIK18252 Kms with pCP20 |
| BIK18256 | BIK18046 Δ | P1 from BW27269 to BIK18254 |
| BIK18258 | BIK18051 Δ | P1 from BW27269 to BIK18255 |
| BIK18260 | BIK18046 Δ | BIK18256 Kms with pCP20 |
| BIK18261 | BIK18051 Δ | BIK18258 Kms with pCP20 |
| BIK18282 | BIK18260 Δ | P1 from BIK18120 to BIK18260 |
| BIK18284 | BIK18261 Δ | P1 from BIK18120 to BIK18261 |
| BIK18286 | BIK18260 Δ( | P1 from BIK18116 to BIK18260 |
| BIK18288 | BIK18261 Δ( | P1 from BIK18116 to BIK18260 |
| BIK18290 | BIK18260 Δ | BIK18282 Kms with pCP20 |
| BIK18291 | BIK18261 Δ | BIK18284 Kms with pCP20 |
| BIK18292 | BIK18260 Δ( | BIK18286 Kms with pCP20 |
| BIK18293 | BIK18261 Δ( | BIK18288 Kms with pCP20 |
| DH5α | F- λ- ϕ 80 | Laboratory collection [ |
| DH5α MCR | DH5α Δo( | S Ohta [ |
| DH10B | F- | Laboratory collection [ |
| Δo(mrr-hsdRMS-mcrBC) | ||
| JWK1944_2 | National Institute of Genetics [ | |
| BIK18308 | DH10B Δ | P1 from JW1944-2 to DH10B |
| BMH71-18 | Δ(lac-proAB) | TaKaRa Bio |
| JC8679 | F- λ- | AJ Clark [ |
| BIK1421 | JC8679 | P1 from BMH71-18 |
| GW2730 | t | GC Walker [ |
| Δ | ||
| BIK1016 | MC1060 (pCHR38) | C Sasakawa [ |
| BIK1185 | GW2730 but | Central part of Tn5 in GW2730 was replaced by Gm |
| BIK1016 × GW2730 | ||
| GC2597 | National Institute of Genetics [ | |
| BIK1218 | JC8679 | N Takahashi [ |
| BIK18262 | BIK18260 | P1 from BIK1421 to BIK18260 |
| BIK18264 | BIK18261 | P1 from BIK1421 to BIK18261 |
| BIK18270 | BIK18260 | P1 fromBIK1218 to BIK18260 |
| BIK18271 | BIK18260 | P1 fromBIK1218 to BIK18260 |
| BIK18275 | BIK18261 | P1 fromBIK1218 to BIK18261 |
| BIK18276 | BIK18261 | P1 fromBIK1218 to BIK18261 |
| BIK18266 | BIK18260 | P1 from GC2597 to BIK18260 |
| BIK18268 | BIK18261 | P1 from GC2597 to BIK18261 |
| BIK18278 | BIK18260 | P1 fromBIK1185 to BIK18266 |
| BIK18280 | BIK18261 | P1 fromBIK1185 to BIK18268 |
Gm, gentamycin-resistance gene; kan, kanamycin-resistance gene; Kms, kanamycin-sensitive; TcS, tetracycline-sensitive.
Figure 4Expression of PvuII methyltransferase causes chromosome methylation and mcrBC-dependent chromosome breakage and cell death. (a) Confirmation of chromosome methylation. BIK18260 (mcrB1) cells carrying pEF24 (pvuIIM under the pBAD promoter; see Table 1), were grown in LB broth under antibiotic selection to the mid-exponential phase, diluted to OD600 = 0.1, and further grown in the presence of 0.002% or 0.002% arabinose (ara) to induce expression of M.PvuII. At the indicated time intervals (in minutes), chromosomal DNA was prepared, digested with PvuII endonuclease (TaKaRa Bio), and subjected to pulsed-field agarose gel electrophoresis. M, λ DNA ladder. (b) Chromosome DNA in BIK18261 (mcrBC+) carrying pEF24 after induction of PvuII methyltransferase. (c) Ethidium-bromide fluorescence in the well was measured for the experiments in (b). (d) Loss of cell viability. The number of viable cells was monitored in duplicate in two independent experiments. Each value was divided by the value at time zero. (e) Cell shape. The cells were recovered 60 minutes after addition of a higher (0.002%) concentration of arabinose. They were stained with DAPI to visualize nucleoids and were observed by phase-contrast (left) and fluorescence (right) microscopy. The scale bar indicates 10 μm.
Figure 5Effect of recA and recBC mutations on cell growth and chromosome changes. (a) Cell growth. BIK18260 (mcrB1), BIK18261 (mcrBC+), BIK18290 (mcrB1 ΔrecA), BIK18291 (mcrBC+ ΔrecA), BIK18292 (mcrB1 ΔrecBC) and BIK18293 (mcrBC+ΔrecBC), carrying pEF24 (pSC101::pvuIIM, see Table 1), were grown in LB broth with 0.2% glucose and selective antibiotics to exponential phase, diluted to OD600 = 0.1 and further grown with or without 0.0002% arabinose. OD600 was monitored at the indicated time intervals after addition of arabinose. Each value was divided by the value at time zero. (b) Chromosomes in uninduced cells. BIK18261 (mcrBC+), BIK18291 (mcrBC+ ΔrecA), and BIK18293 (mcrBC+ ΔrecBC), and their derivatives carrying pEF24 (pSC101::pvuIIM) were grown in LB broth with 0.2% glucose and selective antibiotics to exponential phase. Chromosomal DNA was prepared and subjected to pulsed-field agarose gel electrophoresis. M, λ DNA ladder. (c) Chromosomes after induction. Chromosome DNA in BIK18261 (mcrBC+), BIK18291 (mcrBC+ ΔrecA), and BIK18293 (mcrBC+ ΔrecBC), carrying pEF24 (pSC101::pvuIIM) after induction of PvuII methyltransferase with 0.002% or 0.0002% arabinose. At the indicated time intervals after induction, chromosomal DNA was prepared and subjected to pulsed-field agarose gel electrophoresis. M1, λ DNA ladder; M2, λ DNA cut with HindIII.
Viability loss in various mutants after methyltransferase induction
| Viability (relative) | ||
| 0% arabinose | 0.0002% arabinose | |
| 2.5, 2.3 | 1.9, 0.92 | |
| Δ | 1.3, 1.7 | 0.45, 0.31 |
| Δ | 1.3, 1.2 | 0.43, 0.59 |
| 3.1, 2.5 | 0.21, 0.15 | |
| 2.1, 2.1 | 0.85, 0.88 | |
| 2.1, 2.0 | 0.96, 0.99 | |
| 2.1, 2.0 | 1.4, 1.2 | |
| 2.0, 1.8 | 1.4, 1.2 | |
Viability of several mutant E. coli strains after induction of PvuII methyltransferase was measured. The number of viable cells was monitored 30 minutes after addition of the lower concentration (0.0002%) of arabinose in two independent experiments. Each value was divided by the value at time zero.
Figure 6Effect of SOS-related mutations on cell growth. BIK18262 (mcrB1 mutS), BIK18264 (mcrBC+mutS), BIK18271 (mcrB1 lexA(Ind-)), BIK18276 (mcrBC+lexA(Ind-)), BIK18278 (mcrB1 lexA(Def)), BIK18280 (mcrBC+ lexA(Def)), carrying pEF24 (pSC101::pvuIIM; see Table 1), were grown in LB broth with 0.2% glucose and selective antibiotics to exponential phase, diluted to OD600 = 0.1 and further grown with or without 0.0002% arabinose. OD600 was monitored at the indicated time intervals after addition of arabinose. Each value was divided by the value at time zero.
Figure 7McrBC-mediated cell death with DNA methyltransferases. Cells (BIK18308) harboring pEF46 (PBAD-mcrBC; see Materials and Methods) and pEF43 (M.PvuII), pSI4 (M.SinI), pNW106RM2-3 (M.MspI), or pBAD30 (vector) were streaked on LB agar plate containing 30 μg/ml chloramphenicol and 25 μg/ml ampicillin, and 0.2% glucose or 0.2% arabinose. Plates were incubated overnight at 37°C.
Figure 8mcrBC-like homologs apparently inserted into an RM gene complex. Open reading frame names indicate enzyme names (REBASE) or locus tags (GenBank).
Figure 9Dot-plot comparison of intragenomic mcrB paralogs. Amino acid sequences of a pair of mcrB paralogs within one genome were plotted against each other.